DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/pkftkq/otc_pharmaceutical) has announced the addition of the "OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide" report to their offering.
OTC Pharmaceuticals - Global Group of Eight (G8) Industry Guide is an essential resource for top-level data and analysis covering the OTC Pharmaceuticals industry in each of the G8 (United States, Canada, Germany, France, United Kingdom, Italy, Russia and Japan) countries. The report includes easily comparable data on market value, volume, segmentation and market share, plus full five year market forecasts. It examines future problems, innovations and potential growth areas within the market.
The G8 countries contributed $71,709.0 million in 2011 to the global OTC pharmaceuticals industry, with a compound annual growth rate (CAGR) of 2.3% between 2007 and 2011.
The G8 countries are expected to reach a value of $82,266.7 million in 2016, with a CAGR of 2.8% over the 2011-16 period.
Among the G8 countries, the US holds the major share of the OTC pharmaceuticals industry. It accounted for a share of 39.5% in 2011.
Among the G8 nations, the US is the leading country in the OTC pharmaceuticals industry, with market revenues of $28,309.4 million in 2011.
- Johnson & Johnson
- GlaxoSmithKline Plc
- Jamieson Laboratories, Ltd.
- The Procter & Gamble Company
- Bayer AG
- Kracie Holdings, Ltd.
- Novartis AG
- Reckitt Benckiser Group plc
- Pfizer Inc.
- Merck & Co., Inc.
For more information visit http://www.researchandmarkets.com/research/pkftkq/otc_pharmaceutical